Discover
NEUP
Neuphoria Therapeutics Inc.
3.81
2 x 3.76
2 x 3.86
bid
ask
-
0.03
0.78%
undefined @ 04:00 PM
3.81 +0.00 (0.00%)
| Ytd | -1.80% | |
| 1y | -47.08% |
3.80
day range
3.84
3.19
52 week range
21.40
| Open | 3.81 | Prev Close | 3.84 | Low | 3.80 | High | 3.84 | Mkt Cap | 20.59M |
| Vol | 30.10K | Avg Vol | 200.68K | EPS | -11.06 | P/E | -0.34 | Forward P/E | N/A |
| Beta | 0.75 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-17 | 50-d Avg | 4.05 | 200-d Avg | 4.36 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.21M | ||
| Research and Development Expense | -518.17K | ||
| Selling, General and Administrative Expense | 1.69M | ||
| Operating Income | -1.21M | ||
| Income Tax Expense | -34.79K | ||
| Net Income | -505.06K | ||
| Net Income Common Stock | -505.06K | ||
| Net Income Common Stock (USD) | -358.20K | ||
| Consolidated Income | -505.06K | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -539.86K | ||
| Earning Before Interest & Taxes (USD) | -382.88K | ||
| Weighted Average Shares | 5.41M | ||
| Weighted Average Shares Diluted | 5.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.44M | ||
| Cash and Equivalents (USD) | 13.79M | ||
| Trade and Non-Trade Receivables | 1.61M | ||
| Current Assets | 21.66M | ||
| Total Assets | 34.81M | ||
| Current Liabilities | 1.51M | ||
| Total Liabilities | 5.39M | ||
| Accumulated Retained Earnings (Deficit) | -186.89M | ||
| Accumulated Other Comprehensive Income | -2.07M | ||
| Shareholders Equity | 29.42M | ||
| Shareholders Equity (USD) | 20.87M | ||
| Assets Non-Current | 13.15M | ||
| Goodwill and Intangible Assets | 13.15M | ||
| Liabilities Non-Current | 3.87M | ||
| Trade and Non-Trade Payables | 627.18K | ||
| Tax Liabilities | 390.73K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 165.70K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.81M | ||
| Net Cash Flow from Operations | -3.34M | ||
| Effect of Exchange Rate Changes on Cash | 527.06K | ||
| Share Based Compensation | 70.29K | ||